Thomas Dürig

Title: Thomas Dürrig: Innovator in Extended Release Dosage Forms

Introduction

Thomas Dürrig is a notable inventor based in Malvern, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. His work focuses on enhancing the effectiveness of drug delivery systems.

Latest Patents

Dürrig holds a patent for an "Amino acid modulated extended release dosage form." This patent discloses a tableted oral extended release dosage form that comprises a plurality of granules containing an effective amount of a pharmaceutically active compound, at least one amino acid, and an intragranular polymer. The granules are dispersed within a hydrophilic extragranular polymer matrix that hydrates more rapidly than the intragranular polymer. The selection of amino acids is based on their hydropathy characteristics, which depend on the solubility characteristics of the active compound. This innovative approach aims to improve the release profile of medications.

Career Highlights

Throughout his career, Thomas Dürrig has focused on advancing pharmaceutical formulations. His work has led to the development of new methods that enhance the delivery and efficacy of therapeutic agents. With a patent portfolio that includes 1 patent, he continues to contribute to the field of drug delivery.

Collaborations

Dürrig has collaborated with A Reza Fassihi, a fellow professional in the pharmaceutical industry. Their partnership has likely fostered innovative ideas and advancements in the development of extended release formulations.

Conclusion

Thomas Dürrig is a dedicated inventor whose work in extended release dosage forms has the potential to significantly impact the pharmaceutical industry. His innovative approaches to drug delivery continue to pave the way for advancements in medication efficacy.